Is pleased to announce:
Pathology of
Melanocytic
Tumors
May 9-10, 2016
C O N F E R E N C E LO C AT I O N
MEMORIAL SLOAN KETTERING CANCER CENTER
NEW YORK
www.mskcc.org/dermatopathology
To register or for more information, please go to:
Pathology of Melanocytic
Tumors | May 9-10, 2016
TARGET AUDIENCE
The course will be of value to dermatopathologists, general pathologists,
dermatologists, and surgeons, as well as physicians in training.
COURSE OVERVIEW
The course is designed to provide a current review of the pathology
of melanocytic tumors. Traditional and more recently recognized
morphologic features useful for diagnosis will be presented. New modern
ancillary tests will be explained and their use discussed. Emphasis will
be placed on clinic-pathologic correlation as well as the integration of
genetic and genomic findings for diagnosis, prognosis and treatment
selection. Most of the topics will be addressed in lecture format.
At the end of the course cases of high didactic value (e.g., problemtic
melanocytic lesions with known outcome and/or genomic findings)
will be discussed in detail. Participants will have the opportunity
to preview the pathology of these cases online before the course.
COURSE OBJECTIVES
■■ Know important morphologic clues useful for the differential
diagnosis of melanocytic tumors and understand the value as well
as limitations of morphologic findings and clinical correlations.
■■
Be familiar with the spectrum of melanocytic nevi and melanoma
variants.
■■
Understand the sensitivity and specificity of various novel methods
(new immunohistochemical reagents, dermoscopy, cytogenetic and
molecular tests) for the diagnosis of melanocytic tumors.
■■
Have a grasp of modern concepts in melanocyte pathology, with
emphasis on pathologic, genomic and genetic correlations
■■
Know what is relevant to report and communicate to clinicians.
■■
Comprehend the role of the pathologist in determining
treatment options for the patient through molecular and
immunohistochemical analysis.
www.mskcc.org/dermatopathology
Pathology of Melanocytic
Tumors | May 9-10, 2016
FACULTY
MSK COURSE
DIRECTOR
Klaus J.
Busam MD
Professor of Pathology and
Laboratory Medicine,
Weill Medical College of
Cornell University;
Director of
Dermatopathology,
Dept of Pathology, MSK
GUEST FACULTY
GUEST FACULTY
Pedram
Gerami MD
Richard
Scolyer
BMedSci MBBS
MD FRCPA
FRCPath
Associate Professor
of Dermatology,
Northwestern
University
Professor, University
of Sydney, Senior Staff
Specialist of Tissue
Pathology and Diagnostic
Oncology at Royal Prince
Alfred Hospital
MSK FACULTY
MSK FACULTY
Charlotte Ariyan MD PhD
Ashfaq Marghoob MD
Daniel Coit MD FACS
Brian Marr MD
Assistant Attending,
Department of Surgery
Attending, Department of Surgery
Jasmine Francis MD
Assistant Attending, Dept of Surgery,
Ophthamology Service
Travis Hollmann MD PhD
Assistant Attending,
Department of Pathology
Mario Lacouture MD
Attending, Department of Medicine,
Dermatology Service
Assistant Attending, Department of
Surgery, Ophthamology Service
Kishwer Nehal MD
Attending, Department of Medicine,
Dermatology Service
Melissa Pulitzer MD
Assistant Attending,
Department of Pathology
Assistant Attending,
Dept of Medicine,
Dermatology Service
www.mskcc.org/dermatopathology
Pathology of Melanocytic
Tumors | May 9-10, 2016
Monday, May 9
MORNING SESSIONS
7:00-7:55am
BREAKFAST & REGISTRATION
7:55-8:00am
WELCOME AND ANNOUNCEMENTS
Session 1:
Ancillary Methods for Diagnosis,
Prognosis and Treatment
Klaus J. Busam MD
8:00–8:30amImmunohistochemistry
Klaus J. Busam MD
Cytogenetic Analysis
8:30–9:00am
Pedram Gerami MD
9:00–9:30am
Mutation Analysis
Richard Scolyer BMedSci MBBS
MD FRCPA FRCPath
9:30–10:00am
Gene expression studies
10:00–10:30am
BREAK
Session 2:
Prognostic Factors
10:30 –11:00am
Prognostic factors —
how to assess and what to report
Pedram Gerami MD
Richard Scolyer BMedSci MBBS
MD FRCPA FRCPath
Session 3:
Lentigo Maligna
11:00–11:30am
Lentigo maligna – treatment
Kishwer Nehal MD
11:30am–12 noon
12 noon–1:30pm
Lentigo maligna — pathology
Klaus J. Busam MD
LUNCH BREAK
www.mskcc.org/dermatopathology
Pathology of Melanocytic
Tumors | May 9-10, 2016
Monday, May 9
AFTERNOON SESSIONS
Session 4:
Clinical Pearls
1:30pm-1:50pm Dermoscopy for dermatopathologists
1:50–2:10pm
2:10–2:30pm
2:30-3:00pm
Ashfaq Marghoob MD
Dermatologic management of nevi
Pedram Gerami MD
A surgeon’s message to pathologists
Daniel Coit MD FACS
Melanoma therapy-induced
skin lesions
Mario Lacouture MD
3:00–3:30pm
BREAK
Session 5:
Melanocytic Nevi and Melanoma of
Special Sites
3:30–3:45pm
3:45–4:00pm
Pigmented lesions of the conjunctiva
Brian Marr MD
Uveal melanoma
Jasmine Francis MD
4:00–4:15pm
Pathology of ocular melanocytic tumors
4:15-4:30pm
Surgery of acral and
subungual melanoma
4:30–4:45pm
Pathology of acral nevi and melanomas
4:45–5:00pm
Labial and anogenital
melanocytic lesions
Klaus J. Busam MD
Charlotte Ariyan MD PhD
Richard Scolyer BMedSci MBBS
MD FRCPA FRCPath
Travis Hollmann MD PhD
www.mskcc.org/dermatopathology
Pathology of Melanocytic
Tumors | May 9-10, 2016
Tuesday, May 10
MORNING SESSIONS
7:00-7:55am
BREAKFAST
7:55-8:00am
WELCOME AND ANNOUNCEMENTS
Session 6:
Melanocytic Nevi–Diagnosis and
Distinction from Melanoma
Klaus J. Busam MD
8:00–8:20am
Acquired nevi, including dysplastic nevi
Pedram Gerami MD
8:20–8:40am
8:40–9:00am
Blue nevi
Klaus J. Busam MD
9:00–9:15am
Deep penetrating and combined nevi
Richard Scolyer BMedSci MBBS
MD FRCPA FRCPath
Congenital nevi and
proliferative nodules
Pedram Gerami MD
9:15–9:30am
9:30–9:45am
Spitz nevi
Klaus J. Busam MD
Nevi changing under therapy
Melissa Pulitzer MD
9:45–10:00am
Nodal nevi
10:00–10:30am
BREAK
Session 7:
Diagnostic challenges
10:30–10:50am
10:50–11:10am
Richard Scolyer BMedSci MBBS
MD FRCPA FRCPath
Desmoplastic melanoma
Klaus J. Busam MD
Spitzoid melanoma
Pedram Gerami MD
11:10–11:30am
Nevoid melanoma
11:30–11:50am
Blue nevus-like melanoma
11:50–12:00am
12 noon–1:30pm
Klaus J. Busam MD
Richard Scolyer BMedSci MBBS
MD FRCPA FRCPath
DISCUSSION
Klaus J. Busam MD
LUNCH BREAK
www.mskcc.org/dermatopathology
Pathology of Melanocytic
Tumors | May 9-10, 2016
Tuesday, May 10
AFTERNOON SESSIONS / CLOSING
1:30-2:15pm
2:15–3:00pm
3:00–3:45pm
Session 8:
Case Discussions
Cases 1-5
Pedram Gerami MD
Cases 6–10
Richard Scolyer BMedSci MBBS
MD FRCPA FRCPath
Cases 11–15
Klaus J. Busam MD
3:45–4:00pm
DISCUSSION
4:00pm
CLOSING REMARKS
Klaus J. Busam MD
Please complete and return
Educational Credit Request Form to
Reception Desk before you depart.
www.mskcc.org/dermatopathology
REGISTRATION
EARLY* GENERAL
$500 $550 MDs, PhDs and DOs
$250 $300 Residents, Fellows, RNs
and other healthcare providers
*Deadline is March 31, 2016.
Registration includes an electronic syllabus and other related hand-out materials,
continental breakfast, lunch, and refreshment breaks. Special meals are available
upon request, including vegetarian, kosher, or gluten-free. Please let us know if
we can assist you with special dietary needs.
To register, please go to:
www.mskcc.org/dermatopathology
OFFICE OF CONTINUING MEDICAL EDUCATION
Memorial Sloan Kettering Cancer Center
633 Third Avenue, 12th floor, New York, New York 10017
(646) 227-2025 | brodheap@mskcc.org
TARGET AUDIENCE
The course will be of value to
dermatopathologists, general pathologists,
dermatologists, and surgeons, as well as
physicians in training.
COURSE DESIGN
The course will run for two days and will
consist of a series of lectures as well as casebased slide discussions. Digital images of
slides will be available for preview one month
before the start of the course. The lectures
of the course will discuss novel diagnostic
techniques, light microscopic clues for
diagnosis, and prognostic features. Lectures
given by dermatologists and surgeons
emphasize the multidisciplinary approach.
ACCREDITATION STATEMENT
MSK is accredited by the Accreditation
Council for Continuing Medical Education
(ACCME) to provide continuing medical
education for physicians.
AMA CREDIT DESIGNATION STATEMENT
MSK designates this live activity for a
maximum of 11.5 AMA PRA Category 1
Credits™ . Physicians should only claim
credit commensurate with the extent of
their participation in the activity. The AMA
has determined that physicians not licensed
in the United States but who participate in
this CME activity are eligible for 11.5 AMA
PRA Category 1 Credits™ .
EVALUATION
A course evaluation survey sent electronically
will provide attendees with the opportunity to
review the sessions and the speakers and to
identify future educational needs.
FACULTY DISCLOSURE
It is the policy of MSK to make every effort
to insure balance, independence, objectivity,
and scientific rigor in all continuing medical
education activities which it sponsors as an
ACCME accredited provider. In accordance
with ACCME guidelines and standards,
all faculty participating in an activity
sponsored by MSK are expected to disclose
any significant financial interest or other
relationship with the manufacturer(s) of any
commercial product(s) and/or provider(s)
of commercial services which are discussed
by the faculty members in an educational
presentation. As required by the ACCME,
when an unlabeled use of a commercial
product or an investigational use not yet
approved for any purpose is discussed
during an educational activity, MSK requires
the speaker to disclose that the product is
not labeled for the use under discussion or
that the product is still investigational.
OUTCOMES MEASUREMENT SURVEY
Six months after the end of the course an
Outcomes Measurement Survey will be
sent to all participants to help us determine
what positive impacts have been made on
participant practice as a result of the course.
ACCOMMODATIONS
If you’ll be traveling to MSK from out of
town, we recommend that you plan your
overnight stays as soon as possible. To make
the planning a little easier, we’ve negotiated
special rates at select hotels in Manhattan.
Please go to:
www.mskcc.org/locations/visiting-us/
accommodations.
Please be sure
to mark your
calendars for
upcoming
2015
2016
MSK CME
COURSES
ACCREDITATION STATEMENT
MSK is accredited by the
Accreditation Council for
Continuing Medical Education
to sponsor continuing medical
education for physicians.
For course updates, follow:
facebook.com/mskcme
or on Twitter: @mskcme
2015
Thoracic Pathology NYC
September 11-13
Advances in GYG Robotics
September 17-18
Endobronchial Ultrasound
Interventional Bronchoscopy
September 24-25
Mesothelioma Meeting
September 25-26
Thoracic Surgical Oncology
October 2-3
Oncologic FDG PET/CT
October 9-10
Genetics and Genomics of Gynecologic Cancers
October 15-16
Defining the Actionable Genome
October 16-17
Meaning-Centered Psychotherapy October 17
Lymphoid Leukemias
October 18
Dermatology Through the Lens of Medical Informatics
October 22
Dermatologic Care in Oncology
October 23
Musculoskeletal Tumor Pathology October 22-24
Dermoscopy Intermediate
October 23-24
Modern Mgt Urologic Cancers
October 29-31
Complex Skin Cancers
November 20-21
2016
Hem / Onc Review
March 4-7
Perioperative Care
April 29
Lymphoma Symposium
May 13-14
Pathology of Melanocytic Tumors May 9-10
To register or for more information, contact:
OFFICE OF CONTINUING MEDICAL EDUCATION
Memorial Sloan Kettering Cancer Center
633 Third Avenue, 12th Floor, New York, New York 10017
(646) 227-2025 • brodheap@mskcc.org
Or register online:
2015/6
www.mskcc.org/cme